Sleep and quality of life in schizophrenia

Sleep and Quality of Life in Clinical Medicine

Volumn , Issue , 2008, Pages 299-311

  Hofstetter, John R ^a   Mayeda, Aimee ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

dysfunctional beliefs; insomnia; psychosis; Validity

Indexed keywords

EID: 81955162210     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-60327-343-5_31     Document Type: Chapter

References (130)

1. Herrman H, Hawthorne G, Thomas R. Quality of life assessment in people living with psychosis. Soc Psychiatry Psychiatr Epidemiol 2002; 37(11):510-518.
2. Awad AG, Voruganti LN, Heslegrave RJ. A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation. Qual Life Res 1997; 6(1):21-26.
3. Cannon TD, Kaprio J, Lonnqvist J, HuttunenM, Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatry 1998; 55(1):67-74.
4. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry 2006; 11(9):815-836.
5. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13(2):261-276.
6. Benson KL, Zarcone VP. Sleep Abnormalities in Schizophrenia and other Psychotic Disorders. Review of Psychiatry. Washington, D.C.: American Psychiatric Press; 1994; p. 677-705.
7. Benca RM, Obermeyer WH, Thisted RA, Gillin JC. Sleep and psychiatric disorders. A meta-Analysis. Arch Gen Psychiatry 1992; 49(8):651-668.
8. Royuela A, Macias JA, Gil-Verona JA, et al. Sleep in schizophrenia: a preliminary study using the Pittsburgh Sleep Quality Index. Neurobiol Sleep Wakeful Cycle 2002; 2(2): 37-39.
9. Maixner S, Tandon R, Eiser A, Taylor S, DeQuardo JR, Shipley J. Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: A replication and extension. Am J Psychiatry 1998; 155(11):1600-1602.
10. Taylor SF, Tandon R, Shipley JE, Eiser AS. Effect of neuroleptic treatment on polysomnographic measures in schizophrenia. Biol Psychiatry 1991; 30(9):904-912.
11. Wetter TC, Lauer CJ, Gillich G, Pollmacher T. The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs. J Psychiatr Res 1996; 30(6):411-419.
12. Buysse DJ, Reynolds CF, III, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28(2):193-213.
13. Keshavan MS, Reynolds CF, III, Miewald MJ, et al. Delta sleep deficits in schizophrenia: evidence from automated analyses of sleep data. Arch Gen Psychiatry 1998; 55(5):443-448.
14. Benca RM. Sleep in psychiatric disorders. Neurol Clin 1996; 14(4):739-764.
15. Lee JH, Woo JI, Meltzer HY. Effects of clozapine on sleep measures and sleep-Associated changes in growth hormone and cortisol in patients with schizophrenia. Psychiatry Res 2001; 103(2-3):157-166.
16. Tandon R, Shipley JE, Taylor S, et al. Electroencephalographic sleep abnormalities in schizophrenia. Relationship to positive/negative symptoms and prior neuroleptic treatment. Arch Gen Psychiatry 1992; 49(3):185-194.
17. Zarcone VP, Benson KL. BPRS symptom factors and sleep variables in schizophrenia. Psychiatry Res 1997; 66(2-3):111-120.
18. Cortelli P, Gambetti P, Montagna P, Lugaresi E. Fatal familial insomnia: clinical features and molecular genetics. J Sleep Res 1999; 8 Suppl 1:23-29.
19. Tabernero C, Polo JM, Sevillano MD, et al. Fatal familial insomnia: clinical, neuropathological, and genetic description of a Spanish family. J Neurol Neurosurg Psychiatry 2000; 68(6):774-777.
20. Varkevisser M, Kerkhof GA. Chronic insomnia and performance in a 24-h constant routine study. J Sleep Res 2005; 14(1):49-59.
21. How JM, Foo SC, Low E, et al. Effects of sleep deprivation on performance of naval seamen: I. Total sleep deprivation on performance. Ann Acad Med Singapore 1994; 23(5):669-675.
22. Babkoff H, Sing HC, Thorne DR, Genser SG, Hegge FW. Perceptual distortions and hallucinations reported during the course of sleep deprivation. Percept Mot Skills 1989; 68(3 Pt 1):787-798.
23. Devillieres P, Opitz M, Clervoy P, Stephany J. Delusion and sleep deprivation. Encephale 1996; 22(3):229-231.
24. Howland RH. Sleep-onset rapid eye movement periods in neuropsychiatric disorders: implications for the pathophysiology of psychosis. J Nerv Ment Dis 1997; 185(12):730-738.
25. Nishino S, Ripley B, Mignot E, Benson KL, Zarcone VP. CSF hypocretin-1 levels in schizophrenics and controls: relationship to sleep architecture. Psychiatry Res 2002; 110(1):1-7.
26. Shamir E, Laudon M, Barak Y, et al. Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry 2000; 61(5):373-377.
27. Morin CM, Rodrigue S, Ivers H. Role of stress, arousal, and coping skills in primary insomnia. Psychosom Med 2003; 65(2):259-267.
28. Karow A, Moritz S, Lambert M, Schoder S, Krausz M. PANSS syndromes and quality of life in schizophrenia. Psychopathology 2005; 38(6):320-326.
29. Herrman H. Assessing quality of life in people living with psychosis. Epidemiol Psychiatr Soc 2000; 9(1):1-6.
30. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30(6):473-483.
31. Law CW, Chen EY, Cheung EF, et al. Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia. Qual Life Res 2005; 14(8):1803-1811.
32. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998; 46(12):1569-1585.
33. Orsel S, Akdemir A, Dag I. The sensitivity of quality-oflife scale WHOQOL-100 to psychopathological measures in schizophrenia. Compr Psychiatry 2004; 45(1):57-61.
34. Lambert M, Naber D. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 2004; 18 Suppl 2:5-17.
35. Awad AG, Voruganti LN, Heslegrave RJ. Measuring quality of life in patients with schizophrenia. Pharmacoeconomics 1997; 11(1):32-47.
36. Zissi A, Barry MM, Cochrane R. A mediational model of quality of life for individuals with severe mental health problems. Psychol Med 1998; 28(5):1221-1230.
37. Ritsner M, Gibel A, Perelroyzen G, Kurs R, Jabarin M, Ratner Y. Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice: a naturalistic comparative study. J Clin Psychopharmacol 2004; 24(6):582-591.
38. Katschnig H. Schizophrenia and quality of life. Acta Psychiatr Scand (Suppl) 2000; 102(407):33-37.
39. Voruganti L, Heslegrave R, Awad AG, Seeman MV. Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability. Psychol Med 1998; 28(1):165-172.
40. Kaiser W. Cognitive effects of antipsychotics in schizophrenia and relationship to quality of life. Br J Psychiatry 2000; 176:92-93.
41. Oliver JPJ, Huxley PJ, Bridges K, et al. Quality of Life and Mental Health Services. London: Routledge; 1996.
42. Meijer CJ, Schene AH, Koeter MW. Quality of life in schizophrenia measured by the MOS SF-36 and the Lancashire Quality of Life Profile: a comparison. Acta Psychiatr Scand 2002; 105(4):293-300.
43. Wong JG, Cheung EP, Chen EY, et al. An instrument to assess mental patients' capacity to appraise and report subjective quality of life. Qual Life Res 2005; 14(3):687-694.
44. Lehman AF. The well-being of chronic mental patients. Arch Gen Psychiatry 1983; 40(4):369-373.
45. Khatri N, Romney DM, Pelletier G. Validity of self-reports about quality of life among patients with schizophrenia. Psychiatr Serv 2001; 52(4):534-535.
46. Becchi A, Rucci P, Placentino A, Neri G, de GG. Quality of life in patients with schizophrenia-comparison of self-report and proxy assessments. Soc Psychiatry Psychiatr Epidemiol 2004; 39(5):397-401.
47. Fitzgerald PB, de Castella AR, Filia K, et al. A longitudinal study of patient-And observer-rated quality of life in schizophrenia. Psychiatry Res 2003; 119(1-2):55-62.
48. Ritsner M, Kurs R. Quality of life outcomes in mental illness: schizophrenia, mood and anxiety disorders. Exp Rev Pharmacoeconomics Outcomes Res 2003; 3(2):189-199.
49. Sainfort F, Becker M, Diamond R. Judgments of quality of life of individuals with severe mental disorders: Patient selfreport versus provider perspectives. Am J Psychiatry 1996; 153(4):497-502.
50. Angermeyer MC, Holzinger A, Kilian R, Matschinger H. Quality of life-As defined by schizophrenic patients and psychiatrists. Int J Soc Psychiatry 2001; 47(2):34-42.
51. Whitty P, Browne S, Clarke M et al. Systematic comparison of subjective and objective measures of quality of life at 4-year follow-up subsequent to a first episode of psychosis. J Nerv Ment Dis 2004; 192(12):805-809.
52. Russo J, Trujillo CA, Wingerson D, et al. The MOS 36-Item Short Form Health Survey: reliability, validity, and preliminary findings in schizophrenic outpatients. Med Care 1998; 36(5):752-756.
53. Tunis SL, Croghan TW, Heilman DK, Johnstone BM, Obenchain RL. Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol. Med Care 1999; 37(7):678-691.
54. Kind P. The EuroQoL instrument: an index of HRQOL. In: Spiker B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials, 2 ed. Philadelphia: Lippincott-Raven; 1996: p. 191-201.
55. Prieto L, Sacristan JA, Hormaechea JA, Casado A, Badia X, Gomez JC. Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients. Curr Med Res Opin 2004; 20(6):827-835.
56. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19(8):787-805.
57. Voruganti LN, Heslegrave RJ, Awad AG. Quality of life measurement during antipsychotic drug therapy of schizophrenia. J Psychiatry Neurosci 1997; 22(4):267-274.
58. Bech P. Quality-of-Life measurements for patients taking which drugs? The clinical PCASEE perspective. Pharmacoeconomics 1995; 7(2):141-151.
59. Aksaray G, Oflu S, Kaptanoglu C, Bal C. Neurocognitive deficits and quality of life in outpatients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26(6):1217-1219.
60. Heinisch M, Ludwig M, BullingerM. Psychometrische Testung der "Münchner Lebensqualitäts Dimensionen Liste (MLDL)". In: Bullinger M, Ludwig M, Steinbüchel V, editors. Lebensqualit ät bei kardiovaskulären Erkrankungen. Toronto: Hogrefe Verlag für Psychologie; 1991: p. 73-90.
61. Franz M, Lis S, Pluddemann K, Gallhofer B. Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients. Br J Psychiatry 1997; 170:422-425.
62. Bullinger M, Kirchberger I, Steinbüchel V. Der Fragebogen Alltagsleben -ein Verfahren zutErfassung der gesundheitsbezogenen Lebensqualität. Z Med Psychol 1993; 3:121-131.
63. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993; 29(2):321-326.
64. Gupta S, Kulhara P, Verma SK. Quality of life in schizophrenia and dysthymia. Acta Psychiatr Scand 1998; 97(4):290-296.
65. Bigelow DA, McFarland BH, Olson MM. Quality of life of community mental health program clients: validating a measure. Community Ment Health J 1991; 27(1): 43-55.
66. Green CA, Fenn DS, Moussaoui D, Kadri N, Hoffman WF. Quality of life in treated and never-Treated schizophrenic patients. Acta Psychiatr Scand 2001; 103(2):131-142.
67. Lehman AF. The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Eval Program Plann 1983; 6(2):143-151.
68. Huppert JD, Smith TE. Longitudinal analysis of subjective quality of life in schizophrenia: anxiety as the best symptom predictor. J Nerv Ment Dis 2001; 189(10):669-675.
69. Evans S, Banerjee S, Leese M, Huxley P. The impact of mental illness on quality of life: A comparison of severe mental illness, common mental disorder and healthy population samples. Qual Life Res 2006.
70. Pukrop R, Moller HJ, Steinmeyer EM. Quality of life in psychiatry: a systematic contribution to construct validation and the development of the integrative assessment tool "modular system for quality of life". Eur Arch Psychiatry Clin Neurosci 2000; 250(3):120-132.
71. Bechdolf A, Klosterkotter J, Hambrecht M et al. Determinants of subjective quality of life in post acute patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2003; 253(5):228-235.
72. Becker M, Diamond R, Sainfort F. A new patient focused index for measuring quality of life in persons with severe and persistent mental illness. Qual Life Res 1993; 2(4):239-251.
73. Rudnick A. The impact of coping on the relation between symptoms and quality of life in schizophrenia. Psychiatry 2001; 64(4):304-308.
74. Andreasen NC. Psychiatric Status you Currently Have-Baseline Version (PSYCH-BASE). 1989. Iowa City, IA, University of Iowa.
75. Ho BC, Andreasen NC, Flaum M, Nopoulos P, Miller D. Untreated initial psychosis: its relation to quality of life and symptom remission in first-episode schizophrenia. Am J Psychiatry 2000; 157(5):808-815.
76. Heinrichs DW, Hanlon TE, Carpenter WT. The quality of life scale: An instrument for assessing the schizophrenic deficit syndrome. Schizophr Bull 1984; 10:388-396.
77. Auquier P, Simeoni MC, Sapin C, et al. Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: the S-QoL. Schizophr Res 2003; 63 (1-2):137-149.
78. Wilkinson G, Hesdon B,Wild D, et al. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry 2000; 177:42-46.
79. Test MA, Greenberg JS, Long JD, Brekke JS, Burke SS. Construct validity of a measure of subjective satisfaction with life of adults with serious mental illness. Psychiatr Serv 2005; 56(3):292-300.
80. Voruganti LN, Awad AG. Personal evaluation of transitions in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr Res 2002; 56(1-2):37-46.
81. Naber D, Walther A, Kircher T, Hayek D, Holzbach R. Subjective effects of neuroleptics predict compliance. In: Gaebel W, Awad AG, editors. Prediction of Neuroleptic Treatment Outcome in Schizophrenia Concepts and Methods. New York: Springer; 1994.
82. de Haan L, Weisfelt M, Dingemans PM, Linszen DH, Wouters L. Psychometric properties of the SubjectiveWell-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale. Psychopharmacology (Berl) 2002; 162(1):24-28.
83. Naber D, Moritz S, Lambert M, et al. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res 2001; 50(1-2):79-88.
84. Heslegrave RJ, Awad AG, Voruganti LN. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci 1997; 22(4):235-243.
85. Packer S, Husted J, Cohen S, Tomlinson G. Psychopathology and quality of life in schizophrenia. J Psychiatry Neurosci 1997; 22(4):231-234.
86. Awad AG, Voruganti LN. Intervention research in psychosis: issues related to the assessment of quality of life. Schizophr Bull 2000; 26(3):557-564.
87. Malla AK, Norman RM, McLean TS, McIntosh E. Impact of phase-specific treatment of first episode of psychosis on Wisconsin Quality of Life Index (client version). Acta Psychiatr Scand 2001; 103(5):355-361.
88. Ritsner M, Kurs R, Gibel A, Hirschmann S, Shinkarenko E, Ratner Y. Predictors of quality of life in major psychoses: a naturalistic follow-up study. J Clin Psychiatry 2003; 64(3): 308-315.
89. Bobes J, Garcia-Portilla P, Saiz PA, Bascaran T, Bousono M. Quality of life measures in schizophrenia. Eur Psychiatry 2005; 20 Suppl 3:S313-S317.
90. Corrigan PW, Buican B. The construct validity of subjective quality of life for the severely mentally ill. J Nerv Ment Dis 1995; 183(5):281-285.
91. Browne S, Garavan J, GervinM, Roe M, Larkin C, O'Callaghan E. Quality of life in schizophrenia: insight and subjective response to neuroleptics. J Nerv Ment Dis 1998; 186(2): 74-78.
92. Lysaker PH, Bell MD, Bryson GJ, Kaplan E. Insight and interpersonal function in schizophrenia. J Nerv Ment Dis 1998; 186(7):432-436.
93. Hasson-Ohayon I, Kravetz S, Roe D, David AS, Weiser M. Insight into psychosis and quality of life. Compr Psychiatry 2006; 47(4):265-269.
94. Karow A, Pajonk FG. Insight and quality of life in schizophrenia: recent findings and treatment implications. Curr Opin Psychiatry 2006; 19:637-641.
95. Iqbal Z, Birchwood M, Chadwick P, Trower P. Cognitive approach to depression and suicidal thinking in psychosis. 2. Testing the validity of a social ranking model. Br J Psychiatry 2000; 177:522-528.
96. Ritsner M, Ponizovsky A, Endicott J, et al. The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: a naturalistic study. Eur Neuropsychopharmacol 2002; 12(1):31-38.
97. Hansson L, Middelboe T, Merinder L, et al. Predictors of subjective quality of life in schizophrenic patients living in the community. A Nordic multicentre study. Int J Soc Psychiatry 1999; 45(4):247-258.
98. Mercier C, King S. A latent variable causal model of the quality of life and community tenure of psychotic patients. Acta Psychiatr Scand 1994; 89(1):72-77.
99. Mueser KT, Bellack AS, Morrison RL, Wixted JT. Social competence in schizophrenia: premorbid adjustment, social skill, and domains of functioning. J Psychiatr Res 1990; 24(1):51-63.
100. Kentros MK, Terkelsen K, Hull J, Smith TE, Goodman M. The relationship between personality and quality of life in persons with schizoaffective disorder and schizophrenia. Qual Life Res 1997; 6(2):118-122.
101. Hansson L, Eklund M, Bengtsson-Tops A. The relationship of personality dimensions as measured by the temperament and character inventory and quality of life in individuals with schizophrenia or schizoaffective disorder living in the community. Qual Life Res 2001; 10(2):133-139.
102. Ritsner M, Ben-Avi I, Ponizovsky A, Timinsky I, Bistrov E, Modai I. Quality of life and coping with schizophrenia symptoms. Qual Life Res 2003; 12(1):1-9.
103. Skantze K,Malm U, Dencker SJ,May PR, Corrigan P. Comparison of quality of life with standard of living in schizophrenic out-patients. Br J Psychiatry 1992; 161:797-801.
104. Lehman AF. Measures of quality of life among persons with severe and persistent mental disorders. Soc Psychiatry Psychiatr Epidemiol 1996; 31(2):78-88.
105. Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry 1997; 154(1):99-105.
106. Lehman AF, Postrado LT, Rachuba LT. Convergent validation of quality of life assessments for persons with severe mental illnesses. Qual Life Res 1993; 2(5):327-333.
107. Trauer T, Duckmanton RA, Chiu E. A study of the quality of life of the severely mentally ill. Int J Soc Psychiatry 1998; 44(2):79-91.
108. Espie CA. Cognitive behaviour therapy as the treatment of choice for primary insomnia. Sleep Med Rev 1999; 3(2):97-99.
109. Morin CM, Espie CA. Insomnia:A Clinical Guide to Assessment and Treatment. New York: Plenum; 2003.
110. van Dongen HPA, Vitellaro KM, Dinges DF. Individual differences in adult human sleep and wakefulness: Leitmotif for a research agenda. Sleep 2005; 28(4):479-496.
111. Rogers AE, Hwang WT, Scott LD, Aiken LH, Dinges DF. The working hours of hospital staff nurses and patient safety. Health Aff 2004; 23(4):202-212.
112. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep 1999; 22 Suppl 2:S379-S385.
113. Hatoum HT, Kong SX, Kania CM, Wong JM, Mendelson WB. Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees. Pharmacoeconomics 1998; 14(6):629-637.
114. Goder R, Boigs M, Braun S, et al. Impairment of visuospatial memory is associated with decreased slow wave sleep in schizophrenia. J Psychiatr Res 2004; 38(6):591-599.
115. Morin CM, Kowatch RA, Barry T, Walton E. Cognitivebehavior therapy for late-life insomnia. J Consult Clin Psychol 1993; 61(1):137-146.
116. Morin CM, Blais F, Savard J. Are changes in beliefs and attitudes about sleep related to sleep improvements in the treatment of insomnia? Behav Res Ther 2002; 40(7):741-752.
117. Verbeek IH, Konings GM, Aldenkamp AP, Declerck AC, Klip EC. Cognitive behavioral treatment in clinically referred chronic insomniacs: group versus individual treatment. Behav Sleep Med 2006; 4(3):135-151.
118. Rotenberg VS, Indurski P, Kimhi R, et al. The relationship between objective sleep variables and subjective sleep estimation in schizophrenia . Int J Psych Clin 2000; 4(1): 63-67.
119. Hofstetter JR, Mayeda AR, Happel CG, Lysaker PH. Sleep and daily activity preferences in schizophrenia: Associations with neurocognition and symptoms. J Nerv Ment Dis 2003; 191(6):408-410.
120. Kajimura N, Kato M, Okuma T, Onuma T. Effects of zopiclone on sleep and symptoms in schizophrenia: comparison with benzodiazepine hypnotics. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18(3):477-490.
121. Kato M, Kajimura N, Okuma T, et al. Association between delta waves during sleep and negative symptoms in schizophrenia. Pharmaco-EEG studies by using structurally different hypnotics. Neuropsychobiology 1999; 39(3):165-172.
122. Spence SA, Green RD, Wilkinson ID, Hunter MD. Modafinil modulates anterior cingulate function in chronic schizophrenia. Br J Psychiatry 2005; 187:55-61.
123. Rosenthal MH, Bryant SL. Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia. Clin Neuropharmacol 2004; 27(1):38-43.
124. Ritsner M, Kurs R, Ponizovsky A, Hadjez J. Perceived quality of life in schizophrenia: relationships to sleep quality. Qual Life Res 2004; 13(4):783-791.
125. Lysaker PH, Wilt MA, Plascak-Hallberg CD, Brenner CA, Clements CA. Personality dimensions in schizophrenia: associations with symptoms and coping. J Nerv Ment Dis 2003; 191(2):80-86.
126. Hofstetter JR, Lysaker PH, Mayeda AR. Quality of sleep in patients with schizophrenia is associated with quality of life and coping. BMC Psychiatry 2005; 5(1):13-18.
127. Spielberger CD. State-Trait Anxiety Inventory for Adults. Redwood City, CA, Mind Garden, Inc., 1983.
128. Harvey AG, Schmidt DA, Scarna A, Semler CN, Goodwin GM. Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia, and subjects without sleep problems. Am J Psychiatry 2005; 162(1):50-57.
129. Morin CM, Stone J, Trinkle D,Mercer J, Remsberg S. Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia complaints. Psychol Aging 1993; 8(3):463-467.
130. Hofstetter JR, Lysaker PH, Mayeda AR. Dysfunctional Beliefs and Attitudes about Sleep in Schizophrenia. Submitted.